Clinical Trial Detail

NCT ID NCT01948141
Title Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Roswell Park Cancer Institute
Indications

lung squamous cell carcinoma

Therapies

Nintedanib

Age Groups: adult

Additional content available in CKB BOOST